Recombinant human cc10 protein for treatment of influenza

Disclosed is the use of Human CC10 or rhCC10 (uteroglobin) in the manufacture of a medicament for the therapeutic and/or prophylactic treatment of influenza virus infection by reducing the titre of influenza virus in the lung tissue of a patient.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FLAMAND LOUIS PH. D, PILON APRILE L, BORGEAT PIERRE PH. D
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed is the use of Human CC10 or rhCC10 (uteroglobin) in the manufacture of a medicament for the therapeutic and/or prophylactic treatment of influenza virus infection by reducing the titre of influenza virus in the lung tissue of a patient.